Plus Therapeutics, Inc. financial data

Symbol
PSTV on Nasdaq
Location
4200 Marathon Blvd., Suite 200, Austin, TX
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 67.4 % -2.84%
Debt-to-equity -204 % +56.7%
Return On Equity 219 % -53.7%
Return On Assets -211 % -65.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 32.7M shares +455%
Common Stock, Shares, Outstanding 92.2M shares +1516%
Entity Public Float 8.2M USD +41.4%
Common Stock, Value, Issued 92K USD +1433%
Weighted Average Number of Shares Outstanding, Basic 48.4M shares +644%
Weighted Average Number of Shares Outstanding, Diluted 209M shares +1847%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1.39M USD +8.68%
Research and Development Expense 8.05M USD -25.7%
General and Administrative Expense 10M USD +14.3%
Operating Income (Loss) -12.8M USD +9.44%
Nonoperating Income (Expense) -6.25M USD -815%
Net Income (Loss) Attributable to Parent -19M USD -43.8%
Earnings Per Share, Basic -1 USD/shares +30.9%
Earnings Per Share, Diluted -2 USD/shares +31.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.23M USD -54.5%
Other Assets, Current 1.31M USD +39%
Assets, Current 9.21M USD -1.77%
Property, Plant and Equipment, Net 289K USD -60.5%
Operating Lease, Right-of-Use Asset 29K USD -79.1%
Goodwill 372K USD 0%
Other Assets, Noncurrent 45K USD +40.6%
Assets 10.4M USD -7.69%
Accounts Payable, Current 9.47M USD +99.1%
Liabilities, Current 7.32M USD -61.1%
Operating Lease, Liability, Noncurrent 31K USD -63.5%
Liabilities 7.32M USD -61.2%
Retained Earnings (Accumulated Deficit) -506M USD -3.91%
Stockholders' Equity Attributable to Parent 3.03M USD
Liabilities and Equity 10.4M USD -7.69%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -6.17M USD -36.8%
Net Cash Provided by (Used in) Financing Activities 12.4M USD
Net Cash Provided by (Used in) Investing Activities 3.56M USD
Common Stock, Shares Authorized 2B shares +1900%
Common Stock, Shares, Issued 92.4M shares +1450%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9.79M USD
Interest Paid, Excluding Capitalized Interest, Operating Activities 23K USD -68.5%
Deferred Tax Assets, Valuation Allowance 22.6M USD +15.9%
Deferred Tax Assets, Gross 22.6M USD +15.7%
Operating Lease, Liability 75K USD -63.4%
Payments to Acquire Property, Plant, and Equipment 3K USD -92.5%
Lessee, Operating Lease, Liability, to be Paid 80K USD -63.1%
Property, Plant and Equipment, Gross 3.59M USD +4.24%
Operating Lease, Liability, Current 30K USD -67.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 11K USD -81.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 69K USD -52.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure +9.37%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 5K USD -58.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 11K USD -38.9%
Deferred Tax Assets, Operating Loss Carryforwards 15.4M USD +15%
Preferred Stock, Shares Issued 1.95K shares 0%
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 424K USD +3.92%
Operating Lease, Payments 148K USD -26.7%
Additional Paid in Capital 509M USD +6.17%
Preferred Stock, Shares Outstanding 1.95K shares 0%
Depreciation, Depletion and Amortization 146K USD -5.81%
Deferred Tax Assets, Net of Valuation Allowance 15K USD -65.1%
Interest Expense 210K USD -63.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%